Clinical updates, including trial initiations, enrollment status and data readouts and publications: Limbic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aeon, Athira, Axoltis, Curis, Icosavax, ISA, Lisata, Menarini, Obsidian, Qilu, Solascure, Toragen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Dermasensor, Icecure Medical, Mindmics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acurx, Affimed, Aiviva, Azafaros, Capricor, Corvus, Electra, Glycomine, Incyte, Moderna, Novartis, Puma, Sanofi, Syndax, Tarsus, Tharimmune.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lucid Diagnostics, Neurometrix.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Bionomics, Innovent, Merck, Neuren, Qulu, Ribomic, Technoderma.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biomea Fusion, Dantari, Effector, Eisai, Exegi, Intensity, Merarini, Merck & Co., Novartis, Tilt.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABVC, Altrubio, Anixa, Aura, Bristol Myers Squibb, Faron, Hansa, Harmony, Kymera, MC2, Lobe, Merck & Co., Oculis, Puretech, Regeneron, Sanofi, Spago, Spybiotech, Vesper, Wave, Xilio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sight Sciences.